...on pain management. The separation is due to occur when Scintilla closes its acquisitions of Semnur Pharmaceuticals Inc....
...an NDA for ZTlido early next year. Following the Scilex deal, Scintilla agreed to acquire Semnur...
...million in cash, $20 million in Sorrento stock and up to $140 million in milestones. Semnur’s...

...on pain management. The separation is due to occur when Scintilla closes its acquisitions of Semnur Pharmaceuticals Inc....
...acquire Semnur for $40 million in cash and $20 million in Sorrento shares up front. Semnur's...
...The company's investors included Frazier Healthcare Partners , Vivo Capital and Canaan Partners. Scintilla said Semnur's...

...as part of a $6 million private round completed in August by back pain company Semnur Pharmaceuticals Inc....